Skip to main content
GENEMATRIX INC. logo

GENEMATRIX INC. — Investor Relations & Filings

Ticker · 109820 ISIN · KR7109820001 KO Manufacturing
Filings indexed 175 across all filing types
Latest filing 2023-09-27 Director's Dealing
Country KR South Korea
Listing KO 109820

About GENEMATRIX INC.

https://genematrix.net/en

GENEMATRIX INC. is a biotechnology company that develops molecular diagnostic products and promotes new drug development. The company specializes in multiplex real-time PCR technology, which enables the simultaneous detection of multiple pathogens in a single test. Its core product line, NeoPlex™, offers a range of diagnostic assays for infectious diseases, including comprehensive panels for respiratory viruses and bacteria, human papillomavirus (HPV), and tuberculosis. GENEMATRIX focuses on creating innovative platform technologies to advance diagnostics and is also expanding into AI-powered solutions for precision medicine.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a transaction (장내매수 - open market purchase) by an executive (김석준, Vice President) of Genematrix. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2023-09-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). This type of filing is specifically used to report insider transactions (purchases or sales of shares by directors or major shareholders). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2023-09-26 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company 'Genematrix' covering the period from January 1, 2023, to June 30, 2023. It contains detailed financial information, business operations, management discussions, and capital structure data. As it is a comprehensive financial report for a period shorter than a full fiscal year (half-year), it falls under the 'Interim / Quarterly Report' category. H1 2023
2023-08-11 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Genematrix' (주식회사 진매트릭스) covering the period from January 1, 2023, to March 31, 2023. It contains detailed financial data, business operations, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and remuneration limits. This document is an official record of the voting outcomes from the Annual General Meeting, which aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements'.
2023-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion, key financial data, and auditor information for the fiscal year. While it contains financial data, it is a standardized regulatory disclosure form announcing the receipt and submission of the audit report rather than the full annual report document itself. Therefore, it is classified as an Audit Report / Information (AR). FY 2022
2023-03-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.